NO991995L - Nucleic acid and amino acid sequences related to Heliobacter pylori and vaccine compositions thereof - Google Patents

Nucleic acid and amino acid sequences related to Heliobacter pylori and vaccine compositions thereof

Info

Publication number
NO991995L
NO991995L NO991995A NO991995A NO991995L NO 991995 L NO991995 L NO 991995L NO 991995 A NO991995 A NO 991995A NO 991995 A NO991995 A NO 991995A NO 991995 L NO991995 L NO 991995L
Authority
NO
Norway
Prior art keywords
vaccine compositions
amino acid
nucleic acid
sequences related
heliobacter pylori
Prior art date
Application number
NO991995A
Other languages
Norwegian (no)
Other versions
NO991995D0 (en
Inventor
Douglas Smith
Richard A Alm
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO991995D0 publication Critical patent/NO991995D0/en
Publication of NO991995L publication Critical patent/NO991995L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Analytical Chemistry (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Rekombinant eller vesentlig rene fremstillinger av H. pylori polypeptider er beskrevet. Nukelinsyrene som koder for polypeptider er også beskrevet. H. pylori polypeptider er nyttige i diagnostikk og vaksinesammensetninger.Recombinant or substantially pure preparations of H. pylori polypeptides are described. The nucleic acids encoding polypeptides are also described. H. pylori polypeptides are useful in diagnostics and vaccine compositions.

NO991995A 1996-10-28 1999-04-27 Nucleic acid and amino acid sequences related to Heliobacter pylori and vaccine compositions thereof NO991995L (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US73915096A 1996-10-28 1996-10-28
US75973996A 1996-12-06 1996-12-06
US89192897A 1997-07-14 1997-07-14
PCT/US1997/019575 WO1998018323A1 (en) 1996-10-28 1997-10-28 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof

Publications (2)

Publication Number Publication Date
NO991995D0 NO991995D0 (en) 1999-04-27
NO991995L true NO991995L (en) 1999-06-28

Family

ID=27419246

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991995A NO991995L (en) 1996-10-28 1999-04-27 Nucleic acid and amino acid sequences related to Heliobacter pylori and vaccine compositions thereof

Country Status (19)

Country Link
EP (1) EP0973394A4 (en)
JP (1) JP2001504329A (en)
KR (1) KR20000052831A (en)
CN (1) CN1235513A (en)
AR (1) AR009600A1 (en)
AU (1) AU734052B2 (en)
BR (1) BR9712587A (en)
CA (1) CA2265523A1 (en)
EE (1) EE9900176A (en)
ID (1) ID22065A (en)
IL (1) IL129397A0 (en)
IS (1) IS5005A (en)
NO (1) NO991995L (en)
NZ (1) NZ334568A (en)
PL (1) PL333169A1 (en)
SA (1) SA98180918A (en)
SK (1) SK34699A3 (en)
TR (1) TR199900940T2 (en)
WO (1) WO1998018323A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6406703B1 (en) 1993-07-27 2002-06-18 Csl Limited Treatment of H. pylori associated gastroduodenal disease
KR100333113B1 (en) * 1993-07-27 2002-11-27 시에스엘 리미티드 Treatment of h. pylori associated gastroduodenal disease
DE19730425A1 (en) 1997-07-16 1999-01-21 Henkel Teroson Gmbh Heat-curing laundry-resistant shell sealant
JP2002524035A (en) * 1998-07-27 2002-08-06 コナート ラボラトリーズ リミテッド Chlamydia antigens and corresponding DNA fragments and uses thereof
SE9901548D0 (en) * 1999-04-29 1999-04-29 Astra Ab Helicobacter pylori antigens
GB9914945D0 (en) * 1999-06-25 1999-08-25 Smithkline Beecham Biolog Novel compounds
AUPQ347199A0 (en) * 1999-10-15 1999-11-11 Csl Limited Novel polypeptide fragments
AU2001240473A1 (en) 2000-03-08 2001-09-17 Novozymes A/S Variants with altered properties
GB0010371D0 (en) * 2000-04-29 2000-06-14 Astrazeneca Ab Helicobacter pylori antigens
GB0010370D0 (en) * 2000-04-29 2000-06-14 Astrazeneca Ab Helicobacter pylori antigens
JP6078865B2 (en) * 2011-03-17 2017-02-15 国立大学法人三重大学 Antibody production method
CA3007036A1 (en) * 2015-12-14 2017-06-22 Technische Universitat Munchen Helicobacter pylori vaccines
CN115724922B (en) * 2022-07-19 2023-08-22 四川大学华西医院 A kind of Helicobacter pylori vaccine recombinant protein antigen TonB and its preparation method and application
CN115581201A (en) * 2022-08-26 2023-01-10 云南省农业科学院花卉研究所 Diploid rose F induced by stem segment as explant 1 -61 plant regeneration method

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9300139L (en) * 1993-01-19 1994-07-20 Medicarb Ab Preparation of a new drug

Also Published As

Publication number Publication date
TR199900940T2 (en) 1999-09-21
EP0973394A1 (en) 2000-01-26
PL333169A1 (en) 1999-11-22
SA98180918A (en) 2005-12-03
SK34699A3 (en) 2000-04-10
KR20000052831A (en) 2000-08-25
CA2265523A1 (en) 1998-05-07
EE9900176A (en) 1999-12-15
CN1235513A (en) 1999-11-17
AU5093398A (en) 1998-05-22
NO991995D0 (en) 1999-04-27
EP0973394A4 (en) 2005-03-30
AR009600A1 (en) 2000-04-26
ID22065A (en) 1999-08-26
IS5005A (en) 1999-03-18
IL129397A0 (en) 2000-02-17
WO1998018323A1 (en) 1998-05-07
BR9712587A (en) 1999-10-26
AU734052B2 (en) 2001-05-31
JP2001504329A (en) 2001-04-03
NZ334568A (en) 2000-04-28

Similar Documents

Publication Publication Date Title
NO991995L (en) Nucleic acid and amino acid sequences related to Heliobacter pylori and vaccine compositions thereof
GB2181138B (en) Recombinant alveolar surfactant protein
ATE173478T1 (en) VARIANTS OF THE BOvine PANCREATIC TRYPSIN INHIBITOR, THEIR PREPARATION AND USE
AR006188A1 (en) "PHARMACEUTICAL COMPOSITION TO INHIBIT SERINPROTEASE ACTIVITY, IN VITRO METHOD TO INHIBIT SERINPROTEASE ACTIVITY AND METHOD TO PREPARE SUCH COMPOSITION".
ATE168719T1 (en) OSTEOGENIC PEPTIDES
NZ332565A (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
DK0479948T3 (en) Compositions and Methods for the Synthesis of Natriuretic Protein Receptor B and Methods of Use
NO992158L (en) Nucleic acid and amino acid sequences associated with Heliobacter Pylori and vaccine preparations thereof.
DK312787A (en) POLYPEPTIDES, PROCEDURES FOR THEIR PREPARATION, DNA CODING THE POLYPEPTIDES, VECTORS CONTAINING SUCH REVENUES AND MEDICINALS CONTAINING POLYPEPTIDES
DK0463053T3 (en) Preparation and use of anthelmintic agents and protective immunogens
ATE110389T1 (en) THF COMPOSITIONS.
EP0317279A3 (en) Peptides for use in the purification of factor viii
CA2004764A1 (en) Ancrod proteins, their preparation and use
MX9709846A (en) Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics.
DK0540560T3 (en) Ancrod-like proteins, their preparation and use
DK56995A (en) Recombinant lymphotoxin variants
DK200200302A (en) Recombinant polypeptides comprising the amino acid sequence of mature tissue factor inhibitor (TFI), polypeptide fragments thereof, expression vectors encoding them, host cells transformed therewith, and method for producing a ........

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application